P0172 Dynamic and reversible drug tolerance to Cabozantinib in renal cell carcinoma

European Urology 2026

View at publisher
Authors: A. Zaccagnino, H. Ayoubian, K.J. Junker
DOI: 10.1016/s0302-2838(26)01080-8
Cited by: 0

Fields of Study & Subjects

Renal cell carcinoma treatment Bladder and Urothelial Cancer Treatments Prostate Cancer Treatment and Research

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S1
Publication date
13 February 2026
Language
EN